CN101112482A - Medicine for treating traumatic injury - Google Patents
Medicine for treating traumatic injury Download PDFInfo
- Publication number
- CN101112482A CN101112482A CNA2007101392946A CN200710139294A CN101112482A CN 101112482 A CN101112482 A CN 101112482A CN A2007101392946 A CNA2007101392946 A CN A2007101392946A CN 200710139294 A CN200710139294 A CN 200710139294A CN 101112482 A CN101112482 A CN 101112482A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- present
- medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a traditional Chinese medicine, in particular to a drug for treating bruises and sprains. The present invention solves the problem that the drugs for treating bruises and sprains have single effect in the prior art. The present invention includes 21 medicines of membranous milkvetch root, ground beetle, frankincense, myrrh, Sanguis Draconis, red paeony root, drynaria rhizome of fortune, oyster, yanhusuo, sanchi, pyrolusite, Sanguis Draconis, divaricate saposhnikovia root, manchurian wildginger, pyrite, tangerine peel, pricklyash peel, stewed rhubarb, Chinese angelica, Szechuan lovage rhizome and dahurian angelica root. The present invention is characterized in that the present invention combines the principle of three-stage medication for the patients with bone fractures and bone diseases, carries out the treatment with the different formulas and medicines according to the different stages of the patients with the bone diseases and combines the medication features at the different stages, thus the present invention is characterized by removing blood stasis without hurting healthy trends, supplementing vacuity or causing perverse trends; the clinical trials show that the drug has significant effects of relieving swelling and alleviating pain, which can alleviate the clinical symptoms quickly and promote the early formation of the bone callus.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specially a kind of medicine for the treatment of traumatic injury.
Background technology
The modernization of some industries is though bring great convenience, the great misery that frequent vehicle accident also brings to people for people's trip as transportation modernization.This class disease of cause therefrom is mainly based on traumatic injury, and the maintenance rehabilitation in treatment that this class disease is early stage and later stage is similarly important.And the types of drugs of existing treatment traumatic injury is various, and effect is single, mainly is applicable to the wounded's early treatment, but does not have too big effect for patient's later stage rehabilitation.So must develop a kind of at three phase of morning, noon and afternoon comprehensive therapeutic effect medicine preferably.
Summary of the invention
The present invention provides a kind of medicine for the treatment of traumatic injury for the single problem of effect of drugs that solves treatment traumatic injury in the prior art in conjunction with three phase of patient with bone fracture principle of medication.
The present invention is realized that by following technical scheme a kind of medicine for the treatment of traumatic injury is made up of the material medicine of following weight ratio example,
90～120 parts of the Radixs Astragali, 60～77 parts of Eupolyphaga Seu Steleophagas, 60～77 parts of Olibanums, 60～77 parts of Myrrhas,
35～45 parts of Sanguis Draxonis, 50～77 parts of Radix Paeoniae Rubra, 70～90 parts of Rhizoma Drynariae, 60～90 parts of Concha Ostreaes,
57～77 parts of Rhizoma Corydalis, 35～45 parts of Radix Notoginseng, 60～77 parts of pyrolusitums, 90～120 parts of Os Draconis,
55～70 parts of Radix Saposhnikoviaes, 30～45 parts of Herba Asaris, 60～90 parts of Pyritums, 60～77 parts of Pericarpium Citri Reticulataes,
30～50 parts in Pericarpium Zanthoxyli, 55～70 parts of Radix Et Rhizoma Rhei, Radix Angelicae Sinensis 60～77,60～77 parts of Rhizoma Chuanxiongs,
50～77 parts of the Radixs Angelicae Dahuricae.
Best proportioning of the present invention is as follows:
100 parts of the Radixs Astragali, 67 parts of Eupolyphaga Seu Steleophagas, 67 parts of Olibanums, 67 parts of Myrrhas, 40 parts of Sanguis Draxonis,
67 parts of Radix Paeoniae Rubra, 80 parts of Rhizoma Drynariae, 80 parts of Concha Ostreaes, 67 parts of Rhizoma Corydalis, 40 parts of Radix Notoginseng,
67 parts of pyrolusitums, 100 parts of Os Draconis, 67 parts of Radix Saposhnikoviaes, 40 parts of Herba Asaris, 80 parts of Pyritums,
67 parts of Pericarpium Citri Reticulataes, 40 parts in Pericarpium Zanthoxyli, 67 parts of Radix Et Rhizoma Rhei, Radix Angelicae Sinensis 67,67 parts of Rhizoma Chuanxiongs, 67 parts of the Radixs Angelicae Dahuricae.
More than in 21 herbal medicines, Sanguis Draxonis, Radix Notoginseng, that Radix Et Rhizoma Rhei is ground into fine powder is standby, all the other 18 herbal medicines add decocting, obtain decocting liquid, concentrate the clear paste that obtains relative density 1.3～1.4 under 60 ℃ of situations then, and then add fine powder, mixing, drying is ground into fine powder again, makes capsule and gets final product.
In this medicine, kind the invigorating blood circulation of Olibanum stretched muscle, the relatively diffusing blood silt of Myrrha, and promoting blood circulation and stopping pain, detumescence and promoting granulation, two medicines phase 5 brings out the best in each other; For controlling the key medicine that congestion swells and ache; Sanguis Draxonis is invigorated blood circulation and analgesic therapy, and pseudo-ginseng blood-circulation-invigovating stops blooding and do not stay silt, two medicines to need mutually to become silted up and granulation promoting to loose; Eupolyphaga Seu Steleophaga, Pyritum, pyrolusitum removing blood stasis become silted up, and reuniting the fractured tendons and bones is held concurrently with pain relieving, can synthetism be the key medicine of traumatology with Pyritum especially, and above seven flavor medicine is this medicine monarch drug.Radix Angelicae Sinensis, Radix Paeoniae Rubra nourshing blood and promoting blood circulation, removing heat from blood are loose and are become silted up, the Rhizoma Chuanxiong blood-activating and qi-promoting, and the yin nourishing removing heat from blood is the key medicine of treatment blood deficiency deficiency of YIN-blood; The Rhizoma Drynariae kidney tonifying is invigorated blood circulation, and hemostasis is continuous hinders, the Rhizoma Corydalis blood-activating and qi-promoting, pain relieving is used for coagulation of QI-blood, not only invigorated blood circulation but also circulation of qi promoting, Radix Et Rhizoma Rhei, a little less than the effect of invigorating blood circulation is better rushed down and is exerted oneself, more than all Six-element be the ministerial drug of activating blood and removing stasis.The Radix Astragali, sweet tepor, tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, is beneficial to detumescence; Radix Saposhnikoviae, Herba Asari, the Radix Angelicae Dahuricae be with expelling wind and dampness, reducing swelling and alleviating pain; Pericarpium Zanthoxyli, warming middle-JIAO to relieve pain, dispelling wind for relieving itching; Pericarpium Citri Reticulatae, regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm, above Six-element are adjuvant drug.Os Draconis, Concha Ostreae calmness are messenger drug to calm the nerves.
The present invention is according to the theoretical internal treatment of the traumatology of the traditional Chinese medical science, and is sick basic from organic conception in conjunction with the damage patient cause of disease, on the basis of dialectical demonstration, and identification of etiology according to differenciation of symptoms and signs.Think early injury based on qi stagnation blood stasis, the damage later stage is based on QI and blood deficiency.Total symptom is that pain, swelling, functional activity are limited, thus upright its rule of treatment, the initial stage activating blood circulation to dissipate blood stasis, circulation of qi promoting relieves the pain, mid-term promoting the flow of QI in the collateral by warming the meridian, reunion of fractured tendons and bones, later stage benefiting qi and nourishing blood, strong muscles and bones.Radix Notoginseng, Sanguis Draxonis, Olibanum, Myrrha activating blood circulation to dissipate blood stasis in the medicine of proportioning; Joining Rhizoma Corydalis, Rhizoma Chuanxiong, Radix Paeoniae Rubra, circulation of qi promoting relieves the pain; The synthetism of curing the wound of Eupolyphaga Seu Steleophaga, Rhizoma Drynariae, pyrolusitum, Pyritum; Radix Saposhnikoviae, Herba Asari, the Radix Angelicae Dahuricae, the Pericarpium Zanthoxyli promoting the flow of QI in the collateral by warming the meridian; The Radix Paeoniae Rubra clearing away heat and cooling blood; The calmness of calming the nerves of Concha Ostreae, Os Draconis, strong muscles and bones; The Radix Et Rhizoma Rhei activating blood circulation to dissipate blood stasis swings the accent the intestines and stomach, and the merit of relieving constipation is arranged again, is fit to old bed patient's the usefulness of being hard and dry.Comprehensive therapeutic effect has the effect of activating blood circulation to dissipate blood stasis, reducing swelling and alleviating pain, promoting the flow of QI in the collateral by warming the meridian, strong muscles and bones, benefiting qi and nourishing blood, meet patient with bone fracture morning, in, the medication characteristics of three phases of back, having again becomes silted up is not just hindering, tonify deficiency does not stay evil characteristics.From year July in July, 1998 to 2005, utilize the Drug therapy extremity fracture dislocation of optimal proportion preparation of the present invention, traumatic injury, lumbar sprain and QI divergeny, acute lumbar muscle sprain, 860 examples such as joint behind the lumbar vertebrae disorderly disease obtain tangible reducing swelling and alleviating pain, promote the effect of bone injury healing, so that wherein 320 routine analyses are as follows:
This is organized in 320 examples, male's 186 examples, women's 134 examples, the oldest 78 years old, minimum 14 years old, average 41.2 years old.Extremity fracture 121 examples, traumatic injury cause closed soft tissue injury 62 examples, disorderly 27 examples of joint of thoracic vertebra, and lumbar sprain merges lumbar vertebra back joint disorder 82 examples, sprained ankle 28 examples; In the extremity fracture, upper limb 37 examples, dislocation of shoulder 6 examples wherein, the dislocation of the elbow joint 2 examples, in lower limb 84 examples, hip fracture 33 examples, fracture of shaft of femur 20 examples, Patella fracture 11 examples, tibiofibula is rolled over 12 examples, and ankle joint 8 examples are by being aided with drug oral treatment of the present invention after the preliminary treatment.
Observational technique divides A group and B group, and the A group is the soft tissue injury class, and the B group is the fracture class.Criterion of therapeutical effect, A group, what the pain and swelling functional activity recovered in 3 days be excellent, what recovered in 7 days is very, in 14 days recovery be can, it is poor to revert to after 14 days; The B group, be divided into a group b group again, (a) pain and swelling extinction time, (b) time of union of fracture, what (a) pain and swelling disappeared in 14 days is excellent, what disappear in 21 days is can, (b) healing time, 4 all union of fracture be excellent, 6 the week in union of fracture be good, in 8 weeks union of fracture be can, 8 weeks were poor later.
Therapeutic outcome, A are organized in 199 examples, excellent 73 examples, and good 80 examples can 34 examples, differ from 12 examples; Excellent 44 examples among the B group patient, good 21 examples can 36 examples, differ from 20 examples.
Through clinical observation, medicine of the present invention is used for the various closed soft tissue injuries of fracture dislocation, the lumbar sprain and QI divergeny acute lumbar muscle sprain, and the breast lumbar vertebra back joint disorder causes the pain effect remarkable.Characteristics are three phase principle of medication in conjunction with the fractures and bone injuries patient, treat with different square medicines in the different stages according to patient with bone fracture, each stage medication group of features is integrated, having the silt of dispelling is not just hindering, tonify deficiency does not stay evil characteristics, clinical trial proves that this medicine reducing swelling and alleviating pain effect is obvious, and it is fast to improve clinical symptoms, promotes the characteristics that callus early forms.
Model case,
1, Ma, man, 36 years old, peasant, Xinzhou City Hao Cun people, because of stoop labor causes lumbar sprain, symptom waist hip pain at that time, activity is obstructed, through being diagnosed as joint behind the lumbar vertebrae disorderly disease, discutient and analgesic plaster is used in treatment, fully recovers behind the medicine first quarter moon of the present invention for oral administration.
2, Zheng, the woman, 60 years old, Xinzhou City people from Wutai County, because of external force injures left foot portion, swell and ache stiff a couple of days,, be diagnosed as left radius far-end fracture in January, 06 here prescription on individual diagnosis, after through oral medicine after the manual reduction treating plaster fixation, check after one month, callus formation healing in knochenbruch place is removed Gypsum Fibrosum and is gone home to begin training for recovery.
3, Guo, the woman, 52 years old, the Xinzhou City people, because of wound causes right foot outside pain, swelling and stiff tens of hours, in in March, 06 here prescription on individual diagnosis, be diagnosed as right sufficient fifth metatarsal bone basilar part fracture, check fracture fracture place healing through oral the medicine in the fixing back of manual reduction cardboard after one month.
4, Lee, the woman, 40 years old, the peasant, Xinzhou City people from Dingxiang because of wound causes one week of lumbago, through checking to lumbar sprain, fully recovers behind oral the medicine first quarter moon.
5, the Yan, the man, 67 years old, five people of Xinzhou City because of wound causes the patella folding, in June, 06 here prescription on individual diagnosis, through taking medicine of the present invention behind the operation internal fixation, checked after one month, and the X-ray sheet shows that fracture site heals joint function recovery.
6, Nie, the man, 45 years old, the Xinzhou City people, because of wound causes the left anklebone comminuted fracture, in February, 06 here treatment, through oral medicine of the present invention behind the operative treatment, check after two months, callus physically well develops, and is almost recovered.
The specific embodiment
Embodiment 1: a kind of medicine for the treatment of traumatic injury, form by the material medicine of following weight ratio example, and every part is 1 gram,
90 parts of the Radixs Astragali, 60 parts of Eupolyphaga Seu Steleophagas, 60 parts of Olibanums, 60 parts of Myrrhas, 35 parts of Sanguis Draxonis,
50 parts of Radix Paeoniae Rubra, 70 parts of Rhizoma Drynariae, 60 parts of Concha Ostreaes, 57 parts of Rhizoma Corydalis, 35 parts of Radix Notoginseng,
60 parts of pyrolusitums, 90 parts of Os Draconis, 55 parts of Radix Saposhnikoviaes, 30 parts of Herba Asaris, 60 parts of Pyritums,
60 parts of Pericarpium Citri Reticulataes, 30 parts in Pericarpium Zanthoxyli, 55 parts of Radix Et Rhizoma Rhei, 60 parts of Radix Angelicae Sinensis, 60 parts of Rhizoma Chuanxiongs,
50 parts of the Radixs Angelicae Dahuricae.
More than in 21 herbal medicines, Sanguis Draxonis, Radix Notoginseng, that Radix Et Rhizoma Rhei is ground into fine powder is standby, all the other 18 herbal medicines add decocting three times in (water that at every turn adds three to five times of weight), 2 hours for the first time, 1.5 hours for the second time, 1 hour for the third time, collecting decoction, filter, filtrate is concentrated into the clear paste of relative density 1.32 under 60 ℃ of situations, and then adds fine powder, mixing, drying is ground into fine powder again, makes capsule and gets final product.
Embodiment 2: a kind of medicine for the treatment of traumatic injury, form by the material medicine of following weight ratio example, and every part is calculated with 1 gram,
120 parts of the Radixs Astragali, 77 parts of Eupolyphaga Seu Steleophagas, 77 parts of Olibanums, 77 parts of Myrrhas, 45 parts of Sanguis Draxonis,
77 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Drynariae, 90 parts of Concha Ostreaes, 77 parts of Rhizoma Corydalis, 45 parts of Radix Notoginseng,
77 parts of pyrolusitums, 120 parts of Os Draconis, 70 parts of Radix Saposhnikoviaes, 45 parts of Herba Asaris, 90 parts of Pyritums,
77 parts of Pericarpium Citri Reticulataes, 50 parts in Pericarpium Zanthoxyli, 70 parts of Radix Et Rhizoma Rhei, Radix Angelicae Sinensis 77,77 parts of Rhizoma Chuanxiongs, 77 parts of the Radixs Angelicae Dahuricae.
More than in 21 herbal medicines, Sanguis Draxonis, Radix Notoginseng, that Radix Et Rhizoma Rhei is ground into fine powder is standby, all the other 18 herbal medicines add water (five weight to octuple) and fried in shallow oil 6～8 hours, filter decocting liquid, filtrate is concentrated into the clear paste of relative density 1.3～1.4 under 60 ℃ of situations (being generally 1.32), and then adds fine powder, mixing, drying is ground into fine powder again, makes capsule and gets final product.
Embodiment 3: a kind of medicine for the treatment of traumatic injury, form by the material medicine of following weight ratio example, and every part is calculated with 1 gram,
100 parts of the Radixs Astragali, 67 parts of Eupolyphaga Seu Steleophagas, 67 parts of Olibanums, 67 parts of Myrrhas, 40 parts of Sanguis Draxonis,
67 parts of Radix Paeoniae Rubra, 80 parts of Rhizoma Drynariae, 80 parts of Concha Ostreaes, 67 parts of Rhizoma Corydalis, 40 parts of Radix Notoginseng,
67 parts of pyrolusitums, 1 00 parts of Os Draconis, 67 parts of Radix Saposhnikoviaes, 40 parts of Herba Asaris, 80 parts of Pyritums,
67 parts of Pericarpium Citri Reticulataes, 40 parts in Pericarpium Zanthoxyli, 67 parts of Radix Et Rhizoma Rhei, Radix Angelicae Sinensis 67,67 parts of Rhizoma Chuanxiongs, 67 parts of the Radixs Angelicae Dahuricae.
The same embodiment of preparation method.
Claims (2)
1. a treatment drops to the medicine of damage, and it is characterized in that: the material medicine by the following weight ratio example is formed,
90～120 parts of the Radixs Astragali, 60～77 parts of Eupolyphaga Seu Steleophagas, 60～77 parts of Olibanums, 60～77 parts of Myrrhas,
35～45 parts of Sanguis Draxonis, 50～77 parts of Radix Paeoniae Rubra, 70～90 parts of Rhizoma Drynariae, 60～90 parts of Concha Ostreaes,
57～77 parts of Rhizoma Corydalis, 35～45 parts of Radix Notoginseng, 60～77 parts of pyrolusitums, 90～120 parts of Os Draconis,
55～70 parts of Radix Saposhnikoviaes, 30～45 parts of Herba Asaris, 60～90 parts of Pyritums, 60～77 parts of Pericarpium Citri Reticulataes,
30～50 parts in Pericarpium Zanthoxyli, 55～70 parts of Radix Et Rhizoma Rhei, Radix Angelicae Sinensis 60～77,60～77 parts of Rhizoma Chuanxiongs,
50～77 parts of the Radixs Angelicae Dahuricae.
2. treatment according to claim 1 drops to the medicine of damage, it is characterized in that: the material medicine by the following weight ratio example is formed,
100 parts of the Radixs Astragali, 67 parts of Eupolyphaga Seu Steleophagas, 67 parts of Olibanums, 67 parts of Myrrhas, 40 parts of Sanguis Draxonis,
67 parts of Radix Paeoniae Rubra, 80 parts of Rhizoma Drynariae, 80 parts of Concha Ostreaes, 67 parts of Rhizoma Corydalis, 40 parts of Radix Notoginseng,
67 parts of pyrolusitums, 100 parts of Os Draconis, 67 parts of Radix Saposhnikoviaes, 40 parts of Herba Asaris, 80 parts of Pyritums,
67 parts of Pericarpium Citri Reticulataes, 40 parts in Pericarpium Zanthoxyli, 67 parts of Radix Et Rhizoma Rhei, Radix Angelicae Sinensis 67,67 parts of Rhizoma Chuanxiongs, 67 parts of the Radixs Angelicae Dahuricae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007101392946A CN100522216C (en) | 2007-08-25 | 2007-08-25 | Medicine for treating traumatic injury |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007101392946A CN100522216C (en) | 2007-08-25 | 2007-08-25 | Medicine for treating traumatic injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101112482A true CN101112482A (en) | 2008-01-30 |
| CN100522216C CN100522216C (en) | 2009-08-05 |
Family
ID=39021111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007101392946A Expired - Fee Related CN100522216C (en) | 2007-08-25 | 2007-08-25 | Medicine for treating traumatic injury |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100522216C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101961446A (en) * | 2010-10-21 | 2011-02-02 | 张智富 | Micropowder medicament for treating bone fractures and preparation method thereof |
| CN102078421A (en) * | 2010-12-08 | 2011-06-01 | 何永恒 | Chinese medicine external preparation for postoperative analgesia and healing promotion and preparation method thereof |
| CN103340972A (en) * | 2013-06-21 | 2013-10-09 | 陈俊宣 | Traditional Chinese medicine composition for treating traumatic injuries |
| CN103845493A (en) * | 2012-11-28 | 2014-06-11 | 康凤林 | Oral traditional Chinese medicine for treating acute lumbar muscle sprain and preparation method thereof |
| CN104000983A (en) * | 2014-06-04 | 2014-08-27 | 湖州康企药业有限公司 | Medicine for treating rheumatism |
-
2007
- 2007-08-25 CN CNB2007101392946A patent/CN100522216C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101961446A (en) * | 2010-10-21 | 2011-02-02 | 张智富 | Micropowder medicament for treating bone fractures and preparation method thereof |
| CN101961446B (en) * | 2010-10-21 | 2012-10-24 | 张智富 | Micropowder medicament for treating bone fractures and preparation method thereof |
| CN102078421A (en) * | 2010-12-08 | 2011-06-01 | 何永恒 | Chinese medicine external preparation for postoperative analgesia and healing promotion and preparation method thereof |
| CN103845493A (en) * | 2012-11-28 | 2014-06-11 | 康凤林 | Oral traditional Chinese medicine for treating acute lumbar muscle sprain and preparation method thereof |
| CN103340972A (en) * | 2013-06-21 | 2013-10-09 | 陈俊宣 | Traditional Chinese medicine composition for treating traumatic injuries |
| CN103340972B (en) * | 2013-06-21 | 2014-10-22 | 陈俊宣 | Traditional Chinese medicine composition for treating traumatic injuries |
| CN104000983A (en) * | 2014-06-04 | 2014-08-27 | 湖州康企药业有限公司 | Medicine for treating rheumatism |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100522216C (en) | 2009-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN1164308C (en) | Osteological Chinese medicine prepn. | |
| CN101766773A (en) | Chinese medicine prescription for treating talagia | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN100522216C (en) | Medicine for treating traumatic injury | |
| CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
| CN101507802A (en) | Medicine for treating ankylosing spondylitis | |
| CN102526406B (en) | Traditional Chinese medicine plaster for treating cervical spondylotic radiculopathy and preparation method thereof | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN100484538C (en) | Upper, middle and lower part soup, and method for making same | |
| CN103142938A (en) | Plaster for treating traumatic injury and fracture | |
| CN102764393A (en) | Medicine for treating ankylosing spondylitis | |
| CN102552608B (en) | Medicine composition used for treating fracture and bone injury, preparation method thereof, and purpose thereof | |
| CN103446360B (en) | Traditional Chinese medicine capsule preparation for treating lumbar disc herniation and preparation method of traditional Chinese medicine capsule preparation | |
| CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
| CN104161805B (en) | A kind of Chinese medicine that treating caput femoris necrosis and preparation method | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN102441133A (en) | Traditional Chinese medicine used for treating femur head necrosis | |
| CN108785421B (en) | A Chinese medicinal composition for treating fracture and its preparation method | |
| CN101708324B (en) | Plaster used for treating femoral head necrosis and preparation method thereof | |
| CN109432309A (en) | Chinese medicine composition, exterior-applied medical wine and its preparation method and application | |
| CN103417788A (en) | Orally taken traditional Chinese medicine for treating fracture | |
| CN102988762A (en) | Plaster for treating traumatic fracture | |
| CN103656309B (en) | A kind of fracture/bone splits healing ancillary drug compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090805 Termination date: 20120825 |